PRS for Prostate Cancer (PC-PRS)

$1,300.00

Measures inherited polygenic risk for prostate cancer.

Code: AGPP-PC-PRS Category:

"Prevent Prostate Cancer."

Simple DNA Saliva To Uncover Your Inherited Risk For Prostate Cancer

Designed for Arab and Middle Eastern populations

What Is A Polygenic Score?

Who Should Tale This Test?

Why PRS Matters For Prostate Cancer

Personalized Risk: PRS provides an individualized estimate of lifetime prostate cancer risk based on common genetic variants.

Beyond Family History: It identifies risk in men without a known family history or monogenic mutation.

Stronger Stratification: PRS complements PSA and family history, helping distinguish between low-, intermediate-, and high-risk individuals.

Early Detection: Guides earlier and more frequent screening in high-risk individuals, potentially enabling timely diagnosis and treatment.

Precision Prevention: Informs lifestyle counseling and preventive strategies tailored to genetic risk.

Better Resource Use: Helps reduce over-screening in low-risk men and focus healthcare resources on those most at risk.

How It Works - Step By Step

Developed by Avigena (USA) and Novo Genomics (Saudi Arabia), and trusted by top U.S.
institutions, this test is tailored for Middle Eastern and Arab women.
Results are ready in 4 to 8 weeks, giving you time to act early and make informed decisions.

Along with your personalized risk report, eligible patients receive a complimentary virtual
session with an Avigena genetic counselor. We’ll explain your results and help you explore
practical steps to reduce your risk.
Ask your doctor about the PRS for prostate cancer or contact us to learn more.
Your DNA can guide your prevention.